Q: Management A: Based on the lab results and textbook guidance, here is a comprehensive management plan for Mrs. Nagamani G 46F: --- Lab Interpretation Test Result Reference Interpretation ----------------------------------------- Fasting Blood Sugar 150 mg/dL 60–110 Significantly elevated Post-Lunch Blood Sugar 300 mg/dL 80–170 Severely elevated HbA1c 7.6% 6.5% Fair/borderline-poor control Diagnosis: Established Type 2 Diabetes Mellitus with suboptimal glycemic control HbA1c 7.6% = "fair control" per the lab's own scale; falls in 7–8% range indicating need for treatment intensification. --- Management Goals Targets to Aim For Parameter ADA Target AACE Target ----------------------------------- HbA1c ≤7.0% ≤6.5% Fasting glucose 70–130 mg/dL 110 mg/dL 2-hr post-meal glucose 180 mg/dL 140 mg/dL Her current FBS of 150 and PLBS of 300 are significantly above all targets. --- 1. Lifestyle Modification Foundation of All Care - Diet: Reduce refined carbohydrates, white rice, sugary foods/drinks. Follow a low-glycaemic diet — increase vegetables, whole grains, legumes, and fibre. Mediterranean or plant-based dietary patterns have shown benefit in glycaemic control. - Physical activity: At minimum 150 minutes/week of moderate aerobic exercise brisk walking. Combined aerobic + resistance training is superior for HbA1c reduction. - Weight management: Even 5–10% weight loss improves insulin sensitivity significantly. - Avoid: alcohol, smoking, processed foods. --- 2. Pharmacological Management Step 1 — Metformin First-line - If not already on it: Metformin 500 mg twice daily with meals, titrate to 1000 mg twice daily over 4 weeks as tolerated. - Mechanism: reduces hepatic glucose production, improves insulin sensitivity. - Check renal function eGFR before initiating — hold if eGFR 30. Step 2 — Add a Second Agent given PLBS 300 and HbA1c 7.6% Given the degree of post-prandial hyperglycaemia 300 mg/dL, a second agent targeting post-prandial glucose is warranted: Option A — GLP-1 Receptor Agonist preferred if overweight/obese, cardiovascular benefit - e.g., Dulaglutide or Semaglutide — reduces post-prandial glucose, promotes weight loss, low hypoglycaemia risk. Option B — DPP-4 Inhibitor well tolerated, weight neutral - e.g., Sitagliptin 100 mg once daily or Vildagliptin 50 mg twice daily. Option C — SGLT-2 Inhibitor if cardiovascular/renal risk present - e.g., Dapagliflozin 10 mg or Empagliflozin 10 mg — reduces glucose via urinary excretion, cardiorenal benefits. Option D — Sulphonylurea low cost, widely available - e.g., Glimepiride 1–2 mg once daily with breakfast. Risk of hypoglycaemia and weight gain — counsel accordingly. Given PLBS of 300 mg/dL, dual therapy Metformin + one of the above is strongly indicated rather than waiting. Consider Insulin if - HbA1c remains ≥9% despite dual oral therapy, OR - Symptoms of severe hyperglycaemia polyuria, weight loss, OR - Acute illness, surgery, pregnancy. - Typically start with Basal insulin Glargine/Detemir 10 units at bedtime, titrate by 2 units every 3 days until FBS reaches target. --- 3. Monitoring Plan - SMBG: Check fasting glucose daily and 2-hour post-lunch glucose 3–4×/week to identify patterns. - HbA1c: Repeat in 3 months to assess treatment response. - Annual screening: lipid profile, kidney function serum creatinine + urine microalbumin, liver function, eye examination diabetic retinopathy, foot examination neuropathy check. - Blood pressure: Target 140/80 mmHg; consider ACE inhibitor/ARB if BP elevated or microalbuminuria present. --- 4. Patient Education - Recognise symptoms of hypoglycaemia and how to treat it 15g fast carbs rule. - Importance of medication adherence — diabetes is progressive; dose adjustments over time are expected, not a failure. - Sick-day rules: do not stop medications during illness; monitor glucose more frequently. - Foot care: daily inspection, avoid barefoot walking, proper footwear. --- Summary Action Plan 1. Confirm current medications — is she already on any antidiabetic drug? If naïve, start Metformin immediately. 2. Add second agent now given post-prandial glucose of 300 and HbA1c 7.6% — DPP-4i or GLP-1 RA preferred for her age/gender profile. 3. Order baseline labs: renal function, lipids, LFT, urine microalbumin, BP check. 4. Lifestyle counselling — dietary review and structured exercise plan. 5. Review HbA1c in 3 months — if not at target 7%, escalate therapy. --- ⚠️ Important: This information is for clinical guidance only. The treating physician should make the final prescribing decision based on the complete clinical picture, current medications, comorbidities, and the patient's preferences. — Textbook of Family Medicine 9e, Management of T2DM section
